Live chart · TradingView
What it does
Makes the da Vinci system, which enables surgeon-controlled minimally invasive surgery, and Ion for lung biopsies. Most revenue is recurring: instruments, accessories and services for every procedure.
- Ticker
- NASDAQ:ISRG
- Headquarters
- Sunnyvale, EUA
- Founded
- 1995
Evidence Radar
✓ Evidence
- Millions of procedures performed with da Vinci worldwide.
- Launched da Vinci 5 in 2024.
- “Razor and blade” model: every surgery generates revenue.
◷ Promises
- Use surgical data to help surgeons in real time.
⚠ What could go wrong
- Competition from Medtronic, J&J and Chinese makers.
- Hospital budgets.
- Price pressure from public health systems.
Educational content. Not a recommendation to buy or sell any asset.